NCT03600441 2025-04-10FORERUNNERXynomic Pharmaceuticals, Inc.Phase 2 Active not recruiting139 enrolled
NCT04024696 2025-04-10A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese PatientsXynomic Pharmaceuticals, Inc.Phase 1/2 Active not recruiting12 enrolled